
|Articles|January 1, 2002
Supplements and Featured Publications
- Symposium Reporter - Lipid Management
- Volume 8
- Issue 1 Symp
Dyslipidemia of Insulin Resistance Syndrome Explained; Need for Treatment to Reduce Risk Emphasized
Author(s)Henry N. Ginsberg, MD
Advertisement
Articles in this issue
almost 24 years ago
Review of Clinical trial Data Reaffirms Safety of Statin Therapyalmost 24 years ago
Protective Effects of HDL-C and Need to Raise Low Levels Exploredalmost 24 years ago
Question and Answeralmost 24 years ago
New Cholesterol Guidelines Emphasize Risk AssessmentNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Newly Unveiled ACA Premiums Show 26% Average Increase Before Subsidy Expiration
2
Balancing Efficacy and Safety in BTKi Therapy
3
Measles Outbreaks Cause Financial, Public Health Burden in US
4
Empagliflozin Reduces HF Risk After AMI in Patients With or Without Diabetes, CKD
5















































